Walgreens Boots Alliance (NASDAQ:WBA)
Graphique Historique de l'Action
6 Mois : De Avr 2019 à Oct 2019
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its
board of directors has declared a regular quarterly dividend of 44 cents
per share, unchanged from the previous quarter and an increase of 10
percent over the year-ago quarter. The dividend is payable June 12, 2019
to stockholders of record as of May 20, 2019.
Walgreens Boots Alliance and its predecessor company, Walgreen Co., have
paid a dividend in 346 straight quarters (more than 86 years) and have
raised the dividend for 43 consecutive years.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise. The company's heritage of trusted
health care services through community pharmacy care and pharmaceutical
wholesaling dates back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the U.S. and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25 countries and employ more than
415,000 people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with its equity method investments,
has more than 18,500 stores in 11 countries as well as one of the
largest global pharmaceutical wholesale and distribution networks, with
more than 390 distribution centers delivering to more than 230,000
pharmacies, doctors, health centers and hospitals each year in more than
20 countries. In addition, Walgreens Boots Alliance is one of the
world’s largest purchasers of prescription drugs and many other health
and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7, Soap
& Glory, Liz Earle, Sleek MakeUP and Botanics.
Walgreens Boots Alliance is proud to be a force for good, leveraging
many decades of experience and its international scale, to care for
people and the planet through numerous social responsibility and
sustainability initiatives that have an impact on the health and
wellbeing of millions of people.
Walgreens Boots Alliance is included in Fortune magazine’s 2019 list of
the World’s Most Admired Companies and ranked first in the food and
drugstore category. This is the 26th consecutive year that Walgreens
Boots Alliance or its predecessor company, Walgreen Co., has been named
to the list.
More company information is available at www.walgreensbootsalliance.com.
Cautionary Note Regarding Forward-Looking Statements: All statements
in this release that are not historical are forward-looking statements
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are not
guarantees of future performance and involve risks, assumptions and
uncertainties, including those described in Item 1A (Risk Factors) of
our Form 10-K for the fiscal year ended 31 August 2018, which is
incorporated herein by reference, and in other documents that Walgreens
Boots Alliance files or furnishes with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual
results may vary materially. These forward-looking statements speak only
as of the date they are made. Except to the extent required by law,
Walgreens Boots Alliance does not undertake, and expressly disclaims,
any duty or obligation to update publicly any forward-looking statement
after the date of this release, whether as a result of new information,
future events, changes in assumptions or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190418005263/en/
Media RelationsUSA / Fiona Ortiz +1 847 315 6402International
+44 (0) 20 7980 8585Investor RelationsGerald
Gradwell and Jay Spitzer +1 847 315 2922